Hope S Rugo

109PUBLICATIONS
558CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersEconomic models and forecastingCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (109)

|Aug 24, 2026
Elacestrant in Combination with Everolimus for Estrogen Receptor-Positive, HER2-Negative Previously Treated Advanced Breast Cancer: Results from ELEVATE.

|May 29, 2026
Prevention and management of cardiovascular disease in adults with cancer: an International Cardio-Oncology Society (IC-OS) and Multinational Association of Supportive Care in Cancer (MASCC) clinical practice statement.

|May 28, 2026
Prevention and management of cardiovascular disease in adults with cancer: an International Cardio-Oncology Society (IC-OS) and Multinational Association of Supportive Care in Cancer (MASCC) clinical practice statement.

|May 19, 2026
Exploratory Analysis of PTEN Deficiency by Immunohistochemistry from the Phase III CAPItello-291 Trial.

|Mar 30, 2026
OPERA: a phase II study of DHP107 (oral paclitaxel) versus intravenous paclitaxel in patients with HER2-negative recurrent or metastatic breast cancer.

Hope S Rugo, T J Pluard, P Sharma

|Mar 27, 2026
CSF1R Inhibition with Chemotherapy Relieves Systemic Immune Suppression in Patients with Metastatic Triple-Negative Breast Cancer and Boosts Anti-PD-1 Efficacy in Transgenic Mammary Tumors.

Amanda Poissonnier, Hope S Rugo, Wesley Horton

Pageof 19

Frequent Collaborators

16 joint publications

Sara M Tolaney

14 joint publications

Javier Cortes

13 joint publications

Laura Van't Veer

11 joint publications

Laura J Esserman